Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06128239Not ApplicableActive Not Recruiting

Comparing Suicide Prevention Interventions to Guide Follow-up Care: The SPRING Trial

Role: lead

NCT04893447Not ApplicableCompleted

Suicide Prevention Among Recipients of Care

Role: lead

NCT04700137Not ApplicableCompleted

Mental Health Among Patients, Providers, and Staff During the COVID-19 Era

Role: lead

NCT02121769Unknown

Omegaven Expanded Access Protocol

Role: lead

All 4 trials loaded